Sotera Health (NASDAQ:SHC) Announces Earnings Results, Hits Estimates

Sotera Health (NASDAQ:SHCGet Free Report) announced its earnings results on Tuesday. The company reported $0.26 EPS for the quarter, hitting the consensus estimate of $0.26, Yahoo Finance reports. The firm had revenue of $310.24 million for the quarter, compared to analysts’ expectations of $302.17 million. Sotera Health had a return on equity of 51.32% and a net margin of 4.90%. The firm’s quarterly revenue was up 23.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.23 earnings per share. Sotera Health updated its FY24 guidance to $0.67 to $0.75 EPS and its FY 2024 guidance to 0.670-0.750 EPS.

Sotera Health Stock Performance

NASDAQ SHC remained flat at $14.96 on Thursday. 5,398,414 shares of the company were exchanged, compared to its average volume of 1,049,318. The stock has a market capitalization of $4.23 billion, a price-to-earnings ratio of -13.64 and a beta of 2.20. The company’s 50 day moving average price is $15.90 and its 200-day moving average price is $15.02. Sotera Health has a twelve month low of $12.34 and a twelve month high of $19.40. The company has a debt-to-equity ratio of 5.01, a quick ratio of 2.40 and a current ratio of 2.42.

Institutional Trading of Sotera Health

Several large investors have recently added to or reduced their stakes in SHC. MetLife Investment Management LLC acquired a new stake in Sotera Health in the first quarter worth $139,000. State of Wyoming raised its holdings in Sotera Health by 196.0% in the fourth quarter. State of Wyoming now owns 16,019 shares of the company’s stock worth $133,000 after purchasing an additional 10,608 shares during the period. Delphia USA Inc. acquired a new stake in Sotera Health in the fourth quarter worth $104,000. American Century Companies Inc. acquired a new stake in Sotera Health in the fourth quarter worth $102,000. Finally, Bridgefront Capital LLC raised its holdings in Sotera Health by 13.1% in the fourth quarter. Bridgefront Capital LLC now owns 11,918 shares of the company’s stock worth $99,000 after purchasing an additional 1,384 shares during the period. 88.89% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on SHC. Barclays upped their price target on Sotera Health from $17.00 to $19.00 and gave the company an “overweight” rating in a report on Wednesday. KeyCorp assumed coverage on shares of Sotera Health in a research report on Tuesday, February 6th. They set a “sector weight” rating on the stock. TheStreet upgraded shares of Sotera Health from a “d” rating to a “c-” rating in a report on Tuesday. Finally, Royal Bank of Canada decreased their price objective on shares of Sotera Health from $22.00 to $20.00 and set an “outperform” rating for the company in a report on Thursday, November 2nd.

Read Our Latest Report on Sotera Health

Sotera Health Company Profile

(Get Free Report)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing. It also provides microbiological and analytical chemistry testing, and advisory services.

Recommended Stories

Earnings History for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.